Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature
- PMID: 18377612
- DOI: 10.1111/j.1365-4632.2008.03177.x
Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature
Abstract
Background: Unilesional mycosis fungoides (MF) is a rare variant of cutaneous T-cell lymphoma (CTCL), characterized clinically by a solitary lesion and by histopathological features indistinguishable from multilesional MF. The photodynamic therapy (PDT) is a new and effective treatment of precancerous lesions and non-melanoma skin cancers. In recent years it has been used successfully for the treatment of MF.
Methods: We present two cases of unilesional MF treated with 5-Aminolevulinic acid-PDT (ALA-PDT). We used twenty per cent ALA, applied topically to the lesion, and a well defined laser irradiation at 585 nm wavelength from C-Beam laser. Treatment was repeated three times at monthly intervals. Skin biopsies were taken before and after therapy.
Results: Both patients showed clinical remission. The biopsies confirmed a regression of the infiltrate after treatment.
Conclusions: PDT is effective and can be used successfully for MF treatment, particularly for patch and plaque stage MF, including unilesional MF.
Similar articles
-
Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.Eur J Med Res. 2002 Nov 25;7(11):477-9. Eur J Med Res. 2002. PMID: 12568975
-
Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.J Am Acad Dermatol. 2013 Dec;69(6):890-7. doi: 10.1016/j.jaad.2013.07.047. Epub 2013 Sep 14. J Am Acad Dermatol. 2013. PMID: 24041738 Review.
-
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.Br J Dermatol. 2006 Dec;155(6):1262-9. doi: 10.1111/j.1365-2133.2006.07520.x. Br J Dermatol. 2006. PMID: 17107399 Clinical Trial.
-
Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.Dermatol Surg. 2000 Aug;26(8):765-9; discussion 769-70. doi: 10.1046/j.1524-4725.2000.00056.x. Dermatol Surg. 2000. PMID: 10940064
-
Skin directed therapy for mycosis fungoides: a review.J Drugs Dermatol. 2008 Jul;7(7):655-66. J Drugs Dermatol. 2008. PMID: 18664158 Review.
Cited by
-
Emerging treatment options for early mycosis fungoides.Clin Cosmet Investig Dermatol. 2013;6:61-9. doi: 10.2147/CCID.S27482. Epub 2013 Feb 18. Clin Cosmet Investig Dermatol. 2013. PMID: 23450851 Free PMC article.
-
Current evidence and applications of photodynamic therapy in dermatology.Clin Cosmet Investig Dermatol. 2014 May 21;7:145-63. doi: 10.2147/CCID.S35334. eCollection 2014. Clin Cosmet Investig Dermatol. 2014. PMID: 24899818 Free PMC article. Review.
-
Photodynamic Therapy in Primary Cutaneous Skin Lymphoma-Systematic Review.J Clin Med. 2025 Apr 24;14(9):2956. doi: 10.3390/jcm14092956. J Clin Med. 2025. PMID: 40363989 Free PMC article. Review.
-
Innovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustard.Dermatol Clin. 2010 Jul;28(3):501-10. doi: 10.1016/j.det.2010.03.010. Dermatol Clin. 2010. PMID: 20510760 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical